LIVIVO - Search results -

Search results

Result 1 - 10 of total 90

Search options

Article ; Online: Influence of ultraviolet A1 exposures on mood states: a randomized controlled study.

Haapasalo, Annina / Pasternack, Rafael / Kautiainen, Hannu / Ylianttila, Lasse / Snellman, Erna / Partonen, Timo

Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology

2024

Abstract: We investigated the effects of daily ultraviolet A1 (UV-A1, 340-400 nm) exposures on mood states (#R19055, approval on 21 October 2020). Based on our earlier findings of the influence of diurnal preference on mood, we investigated further whether diurnal ...

Abstract	We investigated the effects of daily ultraviolet A1 (UV-A1, 340-400 nm) exposures on mood states (#R19055, approval on 21 October 2020). Based on our earlier findings of the influence of diurnal preference on mood, we investigated further whether diurnal preference plays a role in the influence of UV-A1 on mood states. Forty-one healthy participants aged 19-55 years were randomized to receive either UV-A1 (n = 21) or control (n = 20) exposures (violet light, 390-440 nm). The irradiations were administered on three consecutive mornings on the skin of the buttocks and middle back. Diurnal preference was assessed with the modified 6-item Morningness-Eveningness Questionnaire (mMEQ). Changes in mood were assessed with Total Mood Disturbance (TMD) score of the 40-item Profile of Mood States (POMS) before the first irradiation, immediately after each irradiation and one week after the last irradiation. Mood improved among those subjected to UV-A1 exposures compared with the controls (p = 0.031). Individuals with more pronounced morningness had mood improvement (p = 0.011), whereas those with more pronounced eveningness did not (p = 0.41). At follow-up of one week after the last irradiation the mood improvement had disappeared.
Language	English
Publishing date	2024-05-15
Publishing country	England
Document type	Journal Article
ZDB-ID	2072584-X
ISSN	1474-9092 ; 1474-905X
ISSN (online)	1474-9092
ISSN	1474-905X
DOI	10.1007/s43630-024-00587-6
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Article: Atooppista ihottumaa voidaan hoitaa ennakoivasti.

Snellman, Erna

Duodecim; laaketieteellinen aikakauskirja

2015 Volume 131, Issue 12, Page(s) 1163–1169

Abstract: The inflammation and itching associated with atopic eczema can rob the patient and even the whole family of their night's sleep. Cutaneous symptoms can be quickly alleviated with a glucocorticoid cream. Calcineurin inhibitors are an alternative to ... ...

Title translation	Atopic eczema can be treated in a pre-emptive manner.
Abstract	The inflammation and itching associated with atopic eczema can rob the patient and even the whole family of their night's sleep. Cutaneous symptoms can be quickly alleviated with a glucocorticoid cream. Calcineurin inhibitors are an alternative to glucocorticoids. Regular washing of the skin must not be forgotten. In the treatment of moderate and severe atopic eczema, the frequency of applications of the medicinal cream is decreased only after the itching has ceased. Maintenance therapy does not seem to have more adverse effects than the conventional reactive mode of treatment, and can in fact be recommended especially for adults affected with moderate and severe atopic eczema.
MeSH term(s)	Administration, Cutaneous ; Calcineurin Inhibitors/administration & dosage ; Eczema/prevention & control ; Glucocorticoids/administration & dosage ; Humans ; Hygiene ; Ointments/administration & dosage
Chemical Substances	Calcineurin Inhibitors ; Glucocorticoids ; Ointments
Language	Finnish
Publishing date	2015
Publishing country	Finland
Document type	English Abstract ; Journal Article ; Review
ZDB-ID	127604-9
ISSN	0012-7183
ISSN	0012-7183
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.B 109: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Narrow-band UVB radiation triggers diverse changes in the gene expression and induces the accumulation of M1 macrophages in human skin.

Karisola, Piia / Nikkola, Veera / Joronen, Heli / Ylianttila, Lasse / Grönroos, Mari / Partonen, Timo / Snellman, Erna / Alenius, Harri

Journal of photochemistry and photobiology. B, Biology

2024 Volume 253, Page(s) 112887

Abstract: Background: The underlying molecular mechanisms that determine the biological effects of UVB radiation exposure on human skin are still only partially comprehended.: Objectives: Our goal is to examine the human skin transcriptome and related ... ...

Abstract	Background: The underlying molecular mechanisms that determine the biological effects of UVB radiation exposure on human skin are still only partially comprehended. Objectives: Our goal is to examine the human skin transcriptome and related molecular mechanisms following a single exposure to UVB in the morning versus evening. Methods: We exposed 20 volunteer females to four-fold standard erythema doses (SED4) of narrow-band UVB (309-313 nm) in the morning or evening and studied skin transcriptome 24 h after the exposure. We performed enrichment analyses of gene pathways, predicted changes in skin cell composition using cellular deconvolution, and correlated cell proportions with gene expression. Results: In the skin transcriptome, UVB exposure yielded 1384 differentially expressed genes (DEGs) in the morning and 1295 DEGs in the evening, of which the most statistically significant DEGs enhanced proteasome and spliceosome pathways. Unexposed control samples showed difference by 321 DEGs in the morning vs evening, which was related to differences in genes associated with the circadian rhythm. After the UVB exposure, the fraction of proinflammatory M1 macrophages was significantly increased at both timepoints, and this increase was positively correlated with pathways on Myc targets and mTORC1 signaling. In the evening, the skin clinical erythema was more severe and had stronger positive correlation with the number of M1 macrophages than in the morning after UVB exposure. The fractions of myeloid and plasmacytoid dendritic cells and CD8 T cells were significantly decreased in the morning but not in the evening. Conclusions: NB-UVB-exposure causes changes in skin transcriptome, inhibiting cell division, and promoting proteasome activity and repair responses, both in the morning and in the evening. Inflammatory M1 macrophages may drive the UV-induced skin responses by exacerbating inflammation and erythema. These findings highlight how the same UVB exposure influences skin responses differently in morning versus evening and presents a possible explanation to the differences in gene expression in the skin after UVB irradiation at these two timepoints.
MeSH term(s)	Female ; Humans ; Proteasome Endopeptidase Complex/metabolism ; Skin/radiation effects ; Ultraviolet Rays ; Erythema/etiology ; Macrophages ; Gene Expression
Chemical Substances	Proteasome Endopeptidase Complex (EC 3.4.25.1)
Language	English
Publishing date	2024-03-06
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	623022-2
ISSN	1873-2682 ; 1011-1344
ISSN (online)	1873-2682
ISSN	1011-1344
DOI	10.1016/j.jphotobiol.2024.112887
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 2347: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Ablative fractional laser-assisted photodynamic therapy for lentigo maligna: a prospective pilot study.

Räsänen, J E / Neittaanmäki, N / Jeskanen, L / Pölönen, I / Snellman, E / Grönroos, M

Journal of the European Academy of Dermatology and Venereology : JEADV

2019 Volume 34, Issue 3, Page(s) 510–517

Abstract: Background: Lentigo maligna (LM) is an in situ form of melanoma carrying a risk of progression to invasive lentigo maligna melanoma (LMM). LM poses a clinical challenge, with subclinical extension and high recurrence rates after incomplete surgery. ... ...

Abstract	Background: Lentigo maligna (LM) is an in situ form of melanoma carrying a risk of progression to invasive lentigo maligna melanoma (LMM). LM poses a clinical challenge, with subclinical extension and high recurrence rates after incomplete surgery. Alternative treatment methods have been investigated with varying results. Photodynamic therapy (PDT) with methylaminolaevulinate (MAL) has already proved promising in this respect. Objectives: To investigate the efficacy of ablative fractional laser (AFL)-assisted PDT with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for treating LM. Methods: In this non-sponsored prospective pilot study, ten histologically verified LMs were treated with AFL-assisted PDT three times at 2-week intervals using a light dose of 90 J/cm Results: The complete histopathological clearance rate was 7 out of 10 LMs (70%). The pain during illumination was tolerable, with the mean pain scores for the PDT sessions on a visual assessment scale ranging from 2.9 to 3.8. Some severe skin reactions occurred during the treatment period, however. Conclusions: Ablative fractional laser-assisted PDT showed moderate efficacy in terms of histological clearance. It could constitute an alternative treatment for LM but due to the side effects it should only be considered in inoperable cases.
MeSH term(s)	Aged ; Aged, 80 and over ; Aminolevulinic Acid/analogs & derivatives ; Aminolevulinic Acid/therapeutic use ; Combined Modality Therapy ; Female ; Humans ; Hutchinson's Melanotic Freckle/therapy ; Laser Therapy ; Male ; Middle Aged ; Photochemotherapy ; Pilot Projects ; Prospective Studies ; Skin Neoplasms/therapy
Chemical Substances	BF-200 ALA ; Aminolevulinic Acid (88755TAZ87)
Language	English
Publishing date	2019-10-10
Publishing country	England
Document type	Journal Article
ZDB-ID	1128828-0
ISSN	1468-3083 ; 0926-9959
ISSN (online)	1468-3083
ISSN	0926-9959
DOI	10.1111/jdv.15925
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 3492: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 413: Show issues

Order via subito

Details ▾

Article ; Online: Hexyl aminolevulinate, 5-aminolevulinic acid nanoemulsion and methyl aminolevulinate in photodynamic therapy of non-aggressive basal cell carcinomas: A non-sponsored, randomized, prospective and double-blinded trial.

Salmivuori, M / Grönroos, M / Tani, T / Pölönen, I / Räsänen, J / Annala, L / Snellman, E / Neittaanmäki, N

Journal of the European Academy of Dermatology and Venereology : JEADV

2020 Volume 34, Issue 12, Page(s) 2781–2788

Abstract: Background: In the photodynamic therapy (PDT) of non-aggressive basal cell carcinomas (BCCs), 5-aminolevulinic acid nanoemulsion (BF-200ALA) has shown non-inferior efficacy when compared with methyl aminolevulinate (MAL), a widely used photosensitizer. ... ...

Abstract	Background: In the photodynamic therapy (PDT) of non-aggressive basal cell carcinomas (BCCs), 5-aminolevulinic acid nanoemulsion (BF-200ALA) has shown non-inferior efficacy when compared with methyl aminolevulinate (MAL), a widely used photosensitizer. Hexyl aminolevulinate (HAL) is an interesting alternative photosensitizer. To our knowledge, this is the first study using HAL-PDT in the treatment of BCCs. Objectives: To compare the histological clearance, tolerability (pain and post-treatment reaction) and cosmetic outcome of MAL, BF-200 ALA and low-concentration HAL in the PDT of non-aggressive BCCs. Methods: Ninety-eight histologically verified non-aggressive BCCs met the inclusion criteria, and 54 patients with 95 lesions completed the study. The lesions were randomized to receive LED-PDT in two repeated treatments with MAL, BF-200 ALA or HAL. Efficacy was assessed both clinically and confirmed histologically at three months by blinded observers. Furthermore, cosmetic outcome, pain, post-treatment reactions fluorescence and photobleaching were evaluated. Results: According to intention-to-treat analyses, the histologically confirmed lesion clearance was 93.8% (95% confidence interval [CI] = 79.9-98.3) for MAL, 90.9% (95% CI = 76.4-96.9) for BF-200 ALA and 87.9% (95% CI = 72.7-95.2) for HAL, with no differences between the arms (P = 0.84). There were no differences between the arms as regards pain, post-treatment reactions or cosmetic outcome. Conclusions: Photodynamic therapy with low-concentration HAL and BF-200 ALA has a similar efficacy, tolerability and cosmetic outcome compared to MAL. HAL is an interesting new option in dermatological PDT, since good efficacy is achieved with a low concentration.
MeSH term(s)	Aminolevulinic Acid/therapeutic use ; Carcinoma, Basal Cell/drug therapy ; Humans ; Photochemotherapy ; Photosensitizing Agents/adverse effects ; Prospective Studies ; Skin Neoplasms/drug therapy ; Treatment Outcome
Chemical Substances	Photosensitizing Agents ; Aminolevulinic Acid (88755TAZ87)
Language	English
Publishing date	2020-07-27
Publishing country	England
Document type	Journal Article ; Randomized Controlled Trial
ZDB-ID	1128828-0
ISSN	1468-3083 ; 0926-9959
ISSN (online)	1468-3083
ISSN	0926-9959
DOI	10.1111/jdv.16357
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 3492: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 413: Show issues

Order via subito

Details ▾

Article ; Online: Hyperspectral imaging system in the delineation of Ill-defined basal cell carcinomas: a pilot study.

Salmivuori, M / Neittaanmäki, N / Pölönen, I / Jeskanen, L / Snellman, E / Grönroos, M

Journal of the European Academy of Dermatology and Venereology : JEADV

2018 Volume 33, Issue 1, Page(s) 71–78

Abstract: Background: Basal cell carcinoma (BCC) is the most common skin cancer in the Caucasian population. Eighty per cent of BCCs are located on the head and neck area. Clinically ill-defined BCCs often represent histologically aggressive subtypes, and they ... ...

Abstract	Background: Basal cell carcinoma (BCC) is the most common skin cancer in the Caucasian population. Eighty per cent of BCCs are located on the head and neck area. Clinically ill-defined BCCs often represent histologically aggressive subtypes, and they can have subtle subclinical extensions leading to recurrence and the need for re-excisions. Objectives: The aim of this pilot study was to test the feasibility of a hyperspectral imaging system (HIS) in vivo in delineating the preoperatively lateral margins of ill-defined BCCs on the head and neck area. Methods: Ill-defined BCCs were assessed clinically with a dermatoscope, photographed and imaged with HIS. This was followed by surgical procedures where the BCCs were excised at the clinical border and the marginal strip separately. HIS, with a 12-cm Results: Sixteen BCCs were included. Of these cases, 10 of 16 were the aggressive subtype of BCC and 6 of 16 were nodular, superficial or a mixed type. HIS delineated the lesions more accurately in 12 of 16 of the BCCs compared to the clinical evaluation (4 of 16 wider and 8 of 16 smaller by HIS). In 2 of 16 cases, the HIS-delineated lesion was wider without histopathological confirmation. In 2 of 16 cases, HIS did not detect the histopathologically confirmed subclinical extension. Conclusions: HIS has the potential to be an easy and fast aid in the preoperative delineation of ill-defined BCCs, but further adjustment and larger studies are warranted for an optimal outcome.
MeSH term(s)	Aged ; Aged, 80 and over ; Carcinoma, Basal Cell/diagnostic imaging ; Carcinoma, Basal Cell/pathology ; Carcinoma, Basal Cell/surgery ; Dermoscopy ; Feasibility Studies ; Female ; Head and Neck Neoplasms/diagnostic imaging ; Head and Neck Neoplasms/pathology ; Head and Neck Neoplasms/surgery ; Humans ; Image Processing, Computer-Assisted/methods ; Male ; Middle Aged ; Photography ; Pilot Projects ; Skin Neoplasms/diagnostic imaging ; Skin Neoplasms/pathology ; Skin Neoplasms/surgery
Language	English
Publishing date	2018-06-20
Publishing country	England
Document type	Journal Article
ZDB-ID	1128828-0
ISSN	1468-3083 ; 0926-9959
ISSN (online)	1468-3083
ISSN	0926-9959
DOI	10.1111/jdv.15102
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 3492: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 413: Show issues

Order via subito

Details ▾

Article ; Online: Melatonin immunoreactivity of epidermal skin is higher in the evening than morning but does not account for erythema sensitivity.

Nikkola, Veera / Huotari-Orava, Riitta / Joronen, Heli / Grönroos, Mari / Kautiainen, Hannu / Ylianttila, Lasse / Snellman, Erna / Partonen, Timo

Chronobiology international

2022 Volume 40, Issue 2, Page(s) 132–144

Abstract: The skin is a site of melatonin synthesis, and melatonin has a role in protecting against ultraviolet radiation-induced damage. Ultraviolet B (UVB) induced erythema seems to vary between morning and evening. We investigated whether epidermal melatonin ... ...

Abstract	The skin is a site of melatonin synthesis, and melatonin has a role in protecting against ultraviolet radiation-induced damage. Ultraviolet B (UVB) induced erythema seems to vary between morning and evening. We investigated whether epidermal melatonin immunoreactivities in the morning differed from those in the evening, and whether UVB-induced erythema was associated with these melatonin immunoreactivities in healthy volunteers. Erythema sensitivity of the skin was determined in the morning and in the evening by scoring the Minimal Erythema Dose and quantifying the erythema index (EI). We took biopsies from the non-UVB-exposed skin of healthy volunteers (n = 39) in the morning and in the evening to study melatonin immunoreactivity with immunohistochemistry (IHC). In the IHC staining, there was more melatonin immunoreactivity in the evening than in the morning (
MeSH term(s)	Humans ; Melatonin ; Ultraviolet Rays ; Circadian Rhythm ; Skin ; Erythema
Chemical Substances	Melatonin (JL5DK93RCL)
Language	English
Publishing date	2022-12-28
Publishing country	England
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	998996-1
ISSN	1525-6073 ; 0742-0528
ISSN (online)	1525-6073
ISSN	0742-0528
DOI	10.1080/07420528.2022.2157733
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2068: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: 5-aminolaevulinic acid nanoemulsion is more effective than methyl-5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis: a nonsponsored randomized double-blind multicentre trial.

Räsänen, J E / Neittaanmäki, N / Ylitalo, L / Hagman, J / Rissanen, P / Ylianttila, L / Salmivuori, M / Snellman, E / Grönroos, M

The British journal of dermatology

2019 Volume 181, Issue 2, Page(s) 265–274

Abstract: Background: Daylight photodynamic therapy (DL-PDT) with methyl-5-aminolaevulinate (MAL) is an effective treatment for mild and moderate actinic keratosis (AK).: Objectives: To assess the clinical efficacy, tolerability and cost-effectiveness of 5- ... ...

Abstract	Background: Daylight photodynamic therapy (DL-PDT) with methyl-5-aminolaevulinate (MAL) is an effective treatment for mild and moderate actinic keratosis (AK). Objectives: To assess the clinical efficacy, tolerability and cost-effectiveness of 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) compared with MAL in DL-PDT for grade I-II AKs. Methods: This nonsponsored, prospective randomized double-blind multicentre trial included 69 patients with 767 grade I-II AKs located symmetrically on the face or scalp. A single DL-PDT was given in a randomized split-face design. The primary outcome was clearance of the AKs at 12 months as assessed by a blinded observer. The secondary outcomes were pain, treatment reactions, cosmetic outcome and the cost-effectiveness of the therapy. Results: In the per-patient (half-face) analysis, clearance was better for the BF-200 ALA sides than for those treated with MAL (P = 0·008). In total, BF-200 ALA cleared 299/375 AKs (79·7%) and MAL 288/392 (73·5%) (P = 0·041). The treatment was practically painless with both photosensitizers, the mean pain visual analogue scale being 1·51 for BF-200 ALA and 1·35 for MAL (P = 0·061). Twenty-six patients had a stronger skin reaction on the BF-200 ALA side, seven on the MAL side and 23 displayed no difference (P = 0·001). The cosmetic outcome was excellent or good in > 90% of cases with both photosensitizers (P = 1·000). The cost-effectiveness plane showed that the costs of DL-PDT were similar for both photosensitizers, but the effectiveness was slightly higher for BF-200 ALA. Conclusions: Our results indicate that BF-200 ALA is more effective than MAL in DL-PDT for grade I-II AKs. BF-200 ALA provides slightly better value for money than MAL.
MeSH term(s)	Aged ; Aged, 80 and over ; Aminolevulinic Acid/administration & dosage ; Aminolevulinic Acid/adverse effects ; Aminolevulinic Acid/analogs & derivatives ; Aminolevulinic Acid/economics ; Cost-Benefit Analysis ; Female ; Humans ; Keratosis, Actinic/diagnosis ; Keratosis, Actinic/drug therapy ; Male ; Middle Aged ; Photochemotherapy/adverse effects ; Photochemotherapy/economics ; Photochemotherapy/methods ; Photosensitizing Agents/administration & dosage ; Photosensitizing Agents/adverse effects ; Photosensitizing Agents/economics ; Prospective Studies ; Treatment Outcome
Chemical Substances	BF-200 ALA ; Photosensitizing Agents ; methyl 5-aminolevulinate (585NM85KYM) ; Aminolevulinic Acid (88755TAZ87)
Language	English
Publishing date	2019-01-02
Publishing country	England
Document type	Comparative Study ; Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
ZDB-ID	80076-4
ISSN	1365-2133 ; 0007-0963
ISSN (online)	1365-2133
ISSN	0007-0963
DOI	10.1111/bjd.17311
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Ui VI Zs.23: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article: Miten ihotautien hoidon järjestelmää tulisi kehittää?

Snellman, Erna

Duodecim; laaketieteellinen aikakauskirja

2005 Volume 121, Issue 21, Page(s) 2255–2257

Title translation	How should be dermatological care be developed?.
MeSH term(s)	Clinical Medicine/organization & administration ; Delivery of Health Care ; Dermatology/organization & administration ; Finland ; Humans ; Leadership ; Medicine/organization & administration ; Policy Making ; Specialization
Language	Finnish
Publishing date	2005
Publishing country	Finland
Document type	Editorial
ZDB-ID	127604-9
ISSN	0012-7183
ISSN	0012-7183
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.B 109: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Hexyl-5-aminolaevulinate 0·2% vs. methyl-5-aminolaevulinate 16% daylight photodynamic therapy for treatment of actinic keratoses: results of a randomized double-blinded pilot trial.

Neittaanmäki-Perttu, N / Grönroos, M / Karppinen, T T / Tani, T T / Snellman, E

The British journal of dermatology

2016 Volume 174, Issue 2, Page(s) 427–429

MeSH term(s)	Administration, Cutaneous ; Aged ; Aged, 80 and over ; Aminolevulinic Acid/administration & dosage ; Aminolevulinic Acid/analogs & derivatives ; Double-Blind Method ; Female ; Humans ; Keratosis, Actinic/drug therapy ; Male ; Ointments ; Photochemotherapy/methods ; Photosensitizing Agents/administration & dosage ; Pilot Projects ; Prospective Studies ; Treatment Outcome
Chemical Substances	Ointments ; Photosensitizing Agents ; methyl 5-aminolevulinate (585NM85KYM) ; Aminolevulinic Acid (88755TAZ87) ; 5-aminolevulinic acid hexyl ester (G7H20TKI67)
Language	English
Publishing date	2016-02
Publishing country	England
Document type	Comparative Study ; Letter ; Randomized Controlled Trial
ZDB-ID	80076-4
ISSN	1365-2133 ; 0007-0963
ISSN (online)	1365-2133
ISSN	0007-0963
DOI	10.1111/bjd.13924
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Ui VI Zs.23: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

To top

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito